$VRTX News

Vertex (VRTX) Up 0.2% Since Last Earnings Report: Can It Continue?

Is Vertex Pharmaceuticals (VRTX) Offering An Opportunity After Recent Share Price Consolidation?

Should FDA’s IgA Nephropathy BLA Acceptance for Povetacicept Reshape Vertex Pharmaceuticals’ (VRTX) Investment Narrative?

Got $5,000? 1 Cash-Flow King to Buy and Hold Forever That Wall Street Is Completely Mispricing

FDA Accepts Vertex's BLA for Povetacicept in IgA Nephropathy

Vertex Pharmaceuticals Stock: Is VRTX Underperforming the Healthcare Sector?

Vertex Stock Down Nearly 8% in 3 Months: Time to Buy or Stay Cautious?

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Vertex Announces US FDA Acceptance of Biologics License Application for Accelerated Approval of Povetacicept in IgA Nephropathy

VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX): Affordable Growth with Strong Fundamentals

Vertex Pharmaceuticals Receives FDA Acceptance For Its Biologics License Application Submission For Povetacicept To Treat Immunoglobulin A Nephropathy

Vertex Pharmaceuticals Incorporated (VRTX) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript

Vertex (VRTX) Announces Health Canada Acceptance of NDS for Suzetrigine

Vertex Pharmaceuticals (NASDAQ:VRTX): Strong Growth Meets a Technical Setup for a Potential Breakout

If You Invested $100 In Vertex Pharmaceuticals Stock 20 Years Ago, You Would Have This Much Today

Vertex Announces New Drug Submission for Suzetrigine Has Been Accepted for Review by Health Canada for the Treatment of Moderate-to-Severe Acute Pain in Adults

Vertex Pharmaceuticals Announces Health Canada Has Accepted For Review A New Drug Submission For Suzetrigine For The Treatment Of Moderate-To-Severe Acute Pain In Adults

Assessing Vertex Pharmaceuticals (VRTX) Valuation After Recent Share Price Weakness

Vertex Pharmaceuticals Incorporated (VRTX) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It